BIOMAT Database Logo BIOMAT Database Logo

Prostaglandins E1, E2 and I2: evidence for three distinct actions in vascular smooth muscle. 1978

M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette

UI MeSH Term Description Entries
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Actions of prostaglandins E1 and F2alpha on isolated intrapulmonary vascular smooth muscle.
November 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Effects of prostaglandins E1, E2, A1, and F1-alpha on isolated vascular smooth muscle.
September 1967, The American journal of physiology,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
March 1983, The Journal of pathology,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Prostaglandins E1 and E2 stimulate the proliferation of pulmonary artery smooth muscle cells.
January 1992, Prostaglandins,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Actions of prostaglandin I2 and thromboxane A2 on vascular smooth muscle tissues.
April 1987, Japanese circulation journal,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
December 1980, Surgery,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
January 1981, Thrombosis research,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
September 1982, The Journal of pharmacology and experimental therapeutics,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
A COMPARISON OF THE ACTIONS OF PROSTAGLANDINS F2-ALPHA AND E1 ON SMOOTH MUSCLE.
April 1965, British journal of pharmacology and chemotherapy,
M S Manku, and D F Horrobin, and S C Cunnane, and A I Ally, and M Karmazyn, and R A Karmali, and R O Morgan, and K C Nicolaou, and W E Barnette
Metabolic activity of cholesteryl esters in aortic smooth muscle cells is altered by prostaglandins I2 and E2.
September 1983, Journal of lipid research,
Copied contents to your clipboard!